Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-061846
Filing Date
2009-11-12
Accepted
2009-11-12 17:15:34
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q g21203e10vq.htm 10-Q 205622
2 EX-31.1 g21203exv31w1.htm EX-31.1 7601
3 EX-31.2 g21203exv31w2.htm EX-31.2 7623
4 EX-32.1 g21203exv32w1.htm EX-32.1 4583
5 GRAPHIC g21203g2120300.gif GRAPHIC 6616
  Complete submission text file 0000950123-09-061846.txt   236084
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 091178107
SIC: 2834 Pharmaceutical Preparations